NeuroSolutions Consulting comprises a team of individuals each with at least 15 years of experience in their specialist areas. This group provides our clients with unique expertise unmatched elsewhere, together with a flexibility to routinely exceed client's expectations

Our experience:

• Leading expertise in neurological and gastrointestinal science and drug discovery/development
• Senior management in big Pharma
• Start-up and management of multiple biotechnology companies
• Review and arbitration of more than 200 pitches from biotech to pharma, and leadership of successful in license to pharma
• Leadership of large academic labs and departments
• Track record of delivery of assets into and through Phases I, IIa, IIb and III, and launching in pain, gastrointestinal and neurodegenerative diseases
• Management of exploratory, lead optimisation and clinical development portfolios
• Building public-private partnerships in Europe and Asia

We can provide expert advice on:

• Optimising screening cascades, candidate profiles, preclinical packages and target product profiles to meet the highest standards of biotech and pharma alike
• Innovative translational and clinical proof-of-concept strategies; selection of correct sub-populations, doses and endpoints for neurological and GI diseases
• Preparation for first contact, confidential and due diligence pitches to partners and funders, including pre-diligence review to prepare responses to any identified gaps and issues
• Accessing capabilities in low cost centres
• Fund-raising from venture, pharma and research council funds
• Establishing public-private partnerships in incubator facilities, CRO, academic and industrial centres of excellence

Our existing clients:

• New start-ups and biotechs in Europe, Asia and North America
• Big Pharma
• Venture capital funds and Institutional investors